These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


483 related items for PubMed ID: 19152363

  • 21. Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats.
    Mittra S, Malhotra S, Naruganahalli KS, Chugh A.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):189-93. PubMed ID: 17320854
    [Abstract] [Full Text] [Related]

  • 22. Conformational restriction in novel NAN-190 and MP3022 analogs and their 5-HT(1A) receptor activity.
    Paluchowska MH, Bugno R, Charakchieva-Minol S, Bojarski AJ, Tatarczyńska E, Chojnacka-Wójcik E.
    Arch Pharm (Weinheim); 2006 Sep 30; 339(9):498-506. PubMed ID: 16941730
    [Abstract] [Full Text] [Related]

  • 23. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G, Fiorino F, Perissutti E, Severino B, Gessi S, Cattabriga E, Borea PA, Santagada V.
    Eur J Med Chem; 2001 Sep 30; 36(11-12):873-86. PubMed ID: 11755230
    [Abstract] [Full Text] [Related]

  • 24. α₁-Adrenoceptor and serotonin 5-HT(1A) receptor affinity of homobivalent 4-aminoquinoline compounds: an investigation of the effect of linker length.
    Chen J, Murad AK, Wakelin LP, Denny WA, Griffith R, Finch AM.
    Biochem Pharmacol; 2013 May 15; 85(10):1534-41. PubMed ID: 23524075
    [Abstract] [Full Text] [Related]

  • 25. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines.
    Paluchowska MH, Bugno R, Duszyńska B, Tatarczyńska E, Nikiforuk A, Lenda T, Chojnacka-Wójcik E.
    Bioorg Med Chem; 2007 Nov 15; 15(22):7116-25. PubMed ID: 17825569
    [Abstract] [Full Text] [Related]

  • 26. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2004 Nov 15; 56(6):743-54. PubMed ID: 15662087
    [Abstract] [Full Text] [Related]

  • 27. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V.
    J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097
    [Abstract] [Full Text] [Related]

  • 28. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S, Sallés J.
    Neuropharmacology; 2009 Feb 16; 56(2):455-62. PubMed ID: 18951909
    [Abstract] [Full Text] [Related]

  • 29. 1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.
    Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA.
    Bioorg Med Chem Lett; 2007 Mar 15; 17(6):1646-50. PubMed ID: 17254786
    [Abstract] [Full Text] [Related]

  • 30. Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.
    Leopoldo M, Lacivita E, Colabufo NA, Niso M, Berardi F, Perrone R.
    Bioorg Med Chem; 2007 Aug 01; 15(15):5316-21. PubMed ID: 17517509
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
    Childers WE, Abou-Gharbia MA, Kelly MG, Andree TH, Harrison BL, Ho DM, Hornby G, Huryn DM, Potestio L, Rosenzweig-Lipson SJ, Schmid J, Smith DL, Sukoff SJ, Zhang G, Schechter LE.
    J Med Chem; 2005 May 19; 48(10):3467-70. PubMed ID: 15887953
    [Abstract] [Full Text] [Related]

  • 32. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D, Palmier C, Finana F, De Vries L, Tardif S, Léger C, Bernois S, Heusler P.
    J Pharmacol Exp Ther; 2009 Oct 19; 331(1):222-33. PubMed ID: 19605522
    [Abstract] [Full Text] [Related]

  • 33. WAY 405, a new silent 5-HT (1A) receptor antagonist with low affinity for vascular alpha (1)-adrenoceptors.
    Villalobos-Molina R, Orozco-Méndez M, López-Guerrero JJ, Gallardo-Ortíz IA.
    Auton Autacoid Pharmacol; 2005 Oct 19; 25(4):185-9. PubMed ID: 16176451
    [Abstract] [Full Text] [Related]

  • 34. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA, Sallander J, Benhamú B, Porras E, Campillo M, Pardo L, López-Rodríguez ML.
    J Med Chem; 2009 Apr 23; 52(8):2384-92. PubMed ID: 19326916
    [Abstract] [Full Text] [Related]

  • 35. A new class of arylpiperazine derivatives: the library synthesis on SynPhase lanterns and biological evaluation on serotonin 5-HT(1A) and 5-HT(2A) receptors.
    Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Pawłowski M, Martinez J.
    J Comb Chem; 2004 Apr 23; 6(5):761-7. PubMed ID: 15360211
    [Abstract] [Full Text] [Related]

  • 36. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH, Mokrosz MJ, Charakchieva-Minol S, Duszyńska B, Kozioł A, Wesołowska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003 Apr 23; 55(4):543-52. PubMed ID: 14581712
    [Abstract] [Full Text] [Related]

  • 37. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
    Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E, Pawłowski M, Martinez J.
    Bioorg Med Chem; 2007 Apr 15; 15(8):2907-19. PubMed ID: 17321139
    [Abstract] [Full Text] [Related]

  • 38. N-[omega-[4-(2-methoxyphenyl)-1-piperazinyl]alkyl]-2-quinolinamines as high-affinity fluorescent 5-HT1A receptor ligands.
    Lacivita E, Leopoldo M.
    J Med Chem; 2008 Mar 13; 51(5):1492-5. PubMed ID: 18269229
    [Abstract] [Full Text] [Related]

  • 39. Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.
    Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C.
    J Med Chem; 2003 Nov 06; 46(23):4895-903. PubMed ID: 14584940
    [Abstract] [Full Text] [Related]

  • 40. Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of alpha 1 antagonist WB-4101.
    Bolchi C, Catalano P, Fumagalli L, Gobbi M, Pallavicini M, Pedretti A, Villa L, Vistoli G, Valoti E.
    Bioorg Med Chem; 2004 Sep 15; 12(18):4937-51. PubMed ID: 15336273
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.